Related Experiment Video
Updated: Jan 10, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Phagocytes as Plaque Catalysts: Human Macrophages Actively Generate Pathogenic Aβ42 Fibrils with Seeding and
Katerina Konstantoulea1,2, Meine Ramakers1,2, Sarah C Borrie1,3
1VIB Center for Brain and Disease Research, VIB, 3000 Leuven, Belgium.
Abstract:
The prevailing view frames microglia and macrophages as guardians against amyloid beta (Aβ) accumulation in Alzheimer's disease (AD). Here, we overturn this paradigm by demonstrating that human phagocytic cells-including differentiated THP-1 macrophages and iPSC-derived microglia-are not merely passive responders but active producers of extracellular, seeding-competent Aβ42 fibrils, the amyloid species most strongly linked to parenchymal plaque formation and neurodegeneration. These cell-generated aggregates differ structurally and functionally from synthetic fibrils, exhibiting heightened seeding activity and the ability to cross-seed tau aggregation, a key driver of AD progression. Notably, Aβ42 fibril formation in this system requires active cellular processes and is exacerbated by loss of TREM2, a major AD risk gene. Transcriptomic profiling reveals an early inflammatory response resembling microglial states observed in human AD models, positioning this system as a tractable, human-relevant platform to dissect the interplay between Aβ aggregation, innate immunity, and genetic susceptibility. Our findings suggest that macrophages and microglia play a dual role in AD, acting both as responders and inadvertent catalysts of pathogenic amyloid formation, with implications for early therapeutic intervention.
Insights
Macrophages and microglia actively produce amyloid beta (Aβ) fibrils in Alzheimer's disease (AD), challenging their traditional role. These cell-generated Aβ fibrils are more potent and can accelerate tau pathology, suggesting a dual role in AD pathogenesis.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia and macrophages are traditionally viewed as protective against amyloid beta (Aβ) in Alzheimer's disease (AD).
- The exact mechanisms by which these cells contribute to AD pathogenesis, particularly Aβ aggregation, remain incompletely understood.
Purpose of the Study:
- To investigate the role of human phagocytic cells, specifically macrophages and microglia, in the production of amyloid beta (Aβ) species.
- To characterize the structural and functional properties of cell-generated Aβ fibrils and their impact on tau pathology.
- To explore the influence of genetic factors, such as TREM2, on Aβ fibril formation.
Main Methods:
- Utilized differentiated THP-1 macrophages and induced pluripotent stem cell (iPSC)-derived microglia.
- Characterized extracellular Aβ42 fibrils using structural and functional assays.
- Performed transcriptomic profiling to analyze cellular responses.
- Investigated the effect of TREM2 gene knockout on Aβ fibril formation.
Main Results:
- Human macrophages and microglia actively produce extracellular, seeding-competent Aβ42 fibrils.
- Cell-generated Aβ fibrils exhibit enhanced seeding activity and can cross-seed tau aggregation.
- Aβ42 fibril formation requires active cellular processes and is increased upon loss of TREM2.
- Transcriptomic data revealed inflammatory responses similar to human AD models.
Conclusions:
- Macrophages and microglia play a dual role in AD, acting as both responders to and inadvertent catalysts of pathogenic amyloid formation.
- Cell-derived Aβ fibrils represent a novel pathogenic species with significant implications for AD progression and tau pathology.
- This human-relevant cellular system provides a platform for studying Aβ aggregation, innate immunity, and AD genetics, offering potential avenues for early therapeutic intervention.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Inflammation

